08/06/2020
Cerner and Xealth Collaboration Helps Patients be More Active Participants in Health Care, Well-being
(BUSINESS WIRE) – Xealth, the leader in enabling digital health at scale, and Cerner Corporation (NASDAQ: CERN), a global health care technology company, are working to improve the health care experience and empower patients to be active participants in their treatment and well-being. As part of this agreement, Cerner and LRVHealth have together invested $6 million in Xealth.
07/28/2020
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials.
07/01/2020
Microbrush® Introduces New Nasopharyngeal Test Swabs
Microbrush, a leading US-based global manufacturer and supplier of flocked applicators, has launched a nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.
06/30/2020
Third Frontier awards $2.4 million to Northeast Ohio universities and companies
The Ohio Third Frontier Commission has awarded $2.4 million to two Northeast Ohio universities and eight companies to help them advance new technologies into the marketplace. The funds were part of $5.34 million the state program awarded to universities and businesses across the state from its Technology Validation and Start-up Fund (TVSF).
02/20/2020
Long-term Changes in Gut Metabolite Predict CHD Risk
New longitudinal data underscore the role of the gut microbial metabolite trimethylamine N-oxide (TMAO) as a predictor of coronary heart disease (CHD) but also the potential for diet to modify its deleterious effects.
02/17/2020
Cleveland hospitals ‘get to the heart’ of new cardiac health innovations
Cleveland Clinic has developed a state of the art central monitoring unit and novel algorithm for monitoring.
01/10/2020
FDA Approves 3D-printed Airway Stents Developed by Cleveland Clinic Doctor
The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.
01/09/2020
FDA clears patient-specific airway stents developed by Cleveland Clinic physician
The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.
01/08/2020
FDA Approves 3D-printed Airway Stents Developed by Cleveland Clinic Doctor
The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. The stents are used to keep open the airways of patients with serious breathing disorders, such as those caused by tumors, inflammation, trauma or other masses. Until now, the patient-specific devices were being implanted under FDA’s compassionate use program, which allows patients who have failed all available forms of treatment to receive investigational ones not yet available to the public.
01/02/2020
Top medical innovations for 2020
Advances in medicine transform lives – and this year will be no different. According to Cleveland Clinic’s annual ranking of top medical innovations – new heart medicines take three of the top ten spots.